Avalo Therapeutics Presents Positive Phase 2…

Sy-Klone Celebrates 40 Years of Clean Air Innovation JACKSONVILLE, Fla., Nov. 5, 2026 /PRNewswire/ -- Sy-Klone® (or "Company"), a global leader in advanc L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

Canadian Natural Resources Shares Hit 4-week Low Canadian Natural Resources shares decreased to 69.13 CAD, the lowest since October 2026. Over the past 4 weeks, Canadian Natural Resources gained 1.07%, and in the last 12 months, L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

Renault Target Resumed at EUR36 by Bernstein L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

MÄRKTE-Dax schließt 0,4 Prozent tiefer MÄRKTE-Dax schließt 0,4 Prozent tiefer Frankfurt, 05. Nov (Reuters) - Nachfolgend die Kurse ausgewäh L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

SAM Acquires SSP Innovations and 3-GIS to Support Continued Innovation and Expand AI-Enabled Digital Solutions AUSTIN, Texas--(BUSINESS WIRE)-- SAM, a leading independent provider of mission-critical geospatial, L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

Barnes & Noble returns to Baltimore County with Timonium store [Baltimore Sun:: ] Barnes & Noble is returning to Baltimore County with a new bookstore in Timonium, nearly a decade af L impact | EQUITY | Nov 05, 2026, 05:06 PM UTC

Avalo Therapeutics Presents Positive Phase 2 Abdakibart Data in Hidradenitis Suppurativa

Related stories